Thursday, May 7, 2026

North Korea Claims 20% Cement Output Surge After Kim Jong Un Visit

North Korea's 2026 Spring National Sports Festival opens with over 540 events, while cement production and housing developments surge.

Kim Jong Un Awards Troops for Russia Missions, Builds Wall of Remembrance

Kim Jong Un honors soldiers from overseas operations, awarding titles and medals, while expressing condolences to bereaved families.

2026 Guide: How the Lee-Trump Relationship is Reshaping the Korea-U.S. Economic Landscape

U.S. and South Korea's alliance strengthens under Presidents Lee and Trump, navigating trade, security, and upcoming political challenges.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

World Cancer Day 2026: How Patient-Centered Care is Transforming Cancer Treatment in Asia

The National Cancer Center joins a global campaign for World Cancer Day, promoting People-Centered Care through dialogue with patients.

How Celltrion’s Omlyclo is Dominating Spain’s Omalizumab Market: A First-Mover Success Story

Celltrion's Omlyclo treatment is thriving in Spain, capturing over 60% of the omalizumab market with innovative strategies and strong demand.

Revolutionizing Antibiotic Use: Insights from Korea’s ASP Model Featured in JAMA

Korea's Antimicrobial Stewardship Program gains international recognition for optimizing antibiotic use and addressing resistance issues.

Anthrax, Plague, and BSL-3 Research: South Korea Checks 47 Safety Items, CCTV, and Records

The KDCA confirmed 100% compliance with biosafety standards in inspections of high-risk pathogen facilities and BSL-3 labs.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

GCC2005: The Breakthrough CAR-NK Therapy for T-Cell Lymphoma Unveiled at TCLF 2026

GC Cell presents promising CD5-targeting CAR-NK therapy GCC2005 for T-cell lymphoma, showing significant efficacy and safety at TCLF.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Are Your Favorite Sweets Safe? Arsenic Levels in 28 Candy Products Raise Concerns

A Florida study found arsenic in popular candies, alarming consumers, but food safety officials deem levels safe. Industry disputes findings.

How SK Chemical’s Nose-R Soft Cap Stand Out in Allergy Treatment: A Deep Dive into the OTC Market

SK Chemicals partners with Kyung Nam Pharm to enhance Nose-R Soft Cap sales in pharmacies, boosting allergy treatment distribution.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Pneumonia Death Rates in South Korea: Why Vaccination is Crucial for High-Risk Groups

Pneumonia is South Korea's third leading cause of death; prevention is crucial, especially for high-risk groups after influenza.

Unlocking Rare Diseases: How AI and Whole Genome Sequencing Achieved 46.2% Diagnostic Success in Korea

Three Billion, an AI-based rare disease diagnostic company, collaborates with Seoul National University Hospital on a major genomic study.

How Seers’ mobiCARE and thynC are Transforming Heart Disease Management in Asia

Seers Technology is revolutionizing digital healthcare with AI and wearable tech, achieving strong growth and targeting international markets.

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.